-
Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
-
View Affiliations Hide AffiliationsMirjam J Knolmirjam.knol rivm.nl
-
View Citation Hide Citation
Citation style for this article: . Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018. Euro Surveill. 2018;23(16):pii=18-00158. https://doi.org/10.2807/1560-7917.ES.2018.23.16.18-00158 Received: 28 Mar 2018; Accepted: 19 Apr 2018
- Previous Article
- Table of Contents
- Next Article
Abstract
The annual incidence rate of serogroup W invasive meningococcal disease in the Netherlands increased from < 0.05/100,000 (n < 10) before 2015 to 0.5/100,000 (n = 80) in 2017. Most isolates (94%) belong to clonal complex 11. The incidence rate is highest among < 5 year-olds and 15–24 year-olds. The case fatality rate was 12% (17/138) in 2015–2017. From May 2018, MenACWY vaccination replaces MenC vaccination at age 14 months and from October 2018, 13–14 year-olds are offered MenACWY vaccination.
Full text loading...